新型含咔唑环和芳环/芳稠杂环的N-酰腙衍生物的合成及蛋白酪氨酸磷酸酶1B(PTP1B)抑制活性评价

为寻找高效、低毒的新型蛋白酪氨酸磷酸酶1B(PTP1B)抑制剂,设计并合成出了一系列新型含咔唑环和芳环/芳稠杂环的N-酰腙衍生物6～8和11.利用IR、1H NMR、13C NMR和2D NMR(包括1H-1H COSY和NOESY)谱及元素分析确定了其结构和构型.评价了目标化合物对PTP1B的抑制活性.实验结果表明,目标化合物对PTP1B均有较强的抑制活性,除了化合物N'-[9-(2-氯噻唑-5-甲基)咔唑-3-亚甲基]-2-苯氨基乙酰肼(6a)、N'-[9-(2-氯噻唑-5-甲基)咔唑-3-亚甲基]-2-(4-甲基苯氨基)乙酰肼(6b)、N'-[9-(2-氯噻唑-5-甲基)咔唑-3-亚甲基]-2-(3-硝基苯氨基)乙酰肼(6g)和N'-[9-(2-氯噻唑-5-甲基)咔唑-3-亚甲基]-2-(4-硝基苯氨基)乙酰肼(6h)外,其它化合物的活性均高于阳性对照药物齐墩果酸,其中N,N'-[(9-丁基咔唑基)-3,6-二亚甲基]-2,2'-[二(4-硝基苯氨基)]双乙酰肼(11b)的活性最高,IC50=(0.89±0.06)μmol/L.利用分子对接分别研究了代表目标化合物N'-[9-(2-氯噻唑-5-甲基)咔唑-3-亚甲基]-2-(4-溴苯氨基)乙酰肼(6d)、N'-[9-(2-氯噻唑-5-甲基)咔唑-3-亚甲基]-2-((2-(1-萘氧基)甲基)苯并咪唑-1-基)乙酰肼(7f)和11b与PTP1B酶的结合模式.     

一种结构新颖的苯并噻唑硫醚类化合物的合成及杀菌活性

以各种取代苯并噻唑为侧链结构,对Strobilurins类杀菌剂苯噻菌酯的药效团部分进行修饰,设计合成了18个结构新颖的苯并噻唑硫醚类化合物,结构经1HNMR,MS,元素分析确证.并用X-ray单晶衍射测定了化合物5,5-二甲基-4-甲氧基-3-[2-(苯并噻唑-2-硫甲基)苯基]-2(5H)-呋喃酮(6a)的晶体结构.初步的生物活性测试结果表明,在200mg/L的剂量下部分化合物表现出一定的杀菌活性.     

新型4-芳氨基嘧啶类衍生物的合成及其杀虫活性

以取代苯胺为起始原料,经重氮化、Meerwein芳基化、异硫氰化、加成、甲基化、环化等多步反应合成一系列结构新颖的4-芳氨基嘧啶类衍生物,并测试了目标化合物的杀虫活性.初步杀虫活性结果表明,在质量浓度500mg/L时,大部分化合物对粘虫的致死率为100%;当质量浓度降至20 mg/L时, 2-甲基-4-[N-(2-氯-4-氟苯基)氨基]-5-[2-三氟甲基-4-(苯氧基)苯基]-6-甲基嘧啶(6h)对粘虫和小菜蛾的致死率分别为80%和60%.     

2-苯甲酰基嘧啶类化合物的合成与生物活性

2-嘧啶氧基-N-芳基苄胺类化合物结构经过两次骨架结构优化后得到2-苯甲酰基嘧啶类化合物二次先导结构.在二次先导结构基础上,共设计并合成了36个化合物,所有化合物结构经1H NMR、13C NMR、HRMS确认,并进行了室内杀菌活性筛选,对各部位取代基进行了逐次优化.结果表明2-苯甲酰基嘧啶类化合物中R1取代基以2位卤素或烷基取代的苯环或杂环活性最好;中间苯环6位引入氟原子活性保持;嘧啶环4,6位甲氧基取代活性较好,5位甲基取代活性大大降低;羰基被还原为羟基后活性消失.其中2,3-二氯-N-[2-(4,6-二甲氧基嘧啶-2-甲酰基)苯氧基]-N-甲基苯甲酰胺(4AHl)、2,5-二氯-N-[2-(4,6-二甲氧基嘧啶-2-甲酰基)苯氧基]-N-甲基苯甲酰胺(4AHn)及N-[2-(4,6-二甲氧基嘧啶-2-甲酰基)-3-氟苯氧基]-N,2-二甲基苯甲酰胺(4AFd)对黄瓜白粉病的杀菌活性与对照样苯菌酮相当.     

N-(取代噻唑-2-基)-菊酰胺类化合物的合成及生物活性研究

为了寻求新颖的氨基噻唑类先导化合物,以含各种取代基的2-氨基噻唑在其氨基位置与拟除虫菊酯类农药的活性基团——菊酸采用亚结构对接的方法合成了35个N-(取代噻唑-2-基)-菊酰胺类化合物,经1HNMR,ESI-MS和元素分析对化合物的结构进行了表征.初步生物活性测定表明,化合物3d,6a,6d,4a,4b,4c和4e在600mg/L下对小菜蛾具有100%的杀虫活性,化合物3d和7c在50mg/L下对多种常见病原菌具有显著的杀菌活性,全部化合物没有明显的除草活性.     

N-[4-氯-2-取代氨基甲酰基-6-甲基苯基]-1-芳基-5-氯-3-三氟甲基-1H-吡唑-4-甲酰胺的合成及生物活性

通过改变传统氯虫酰胺中吡唑环上氨基甲酰基与吡啶环之间的相对位置, 或以其它芳环取代原分子中的吡啶环, 设计合成了24个结构新颖的N-[4-氯-2-取代氨基甲酰基-6-甲基苯基]-1-芳基-5-氯-3-三氟甲基-1H-吡唑-4-甲酰胺类化合物. 所有目标化合物的结构均通过¹H NMR谱、 元素分析或高分辨质谱表征确定. 初步的生物活性测试结果表明, 部分化合物对东方粘虫具有较好的杀虫活性, 其中化合物6m在浓度为50 mg/L时具有80%的杀虫活性. 同时, 在浓度为50 mg/L时目标化合物对5种常见病菌具有明显的抑制作用, 其中化合物6n和6x对苹果轮纹菌的抑菌率达62.1%.     

芳氧基稀土化合物引发开环聚合的活性

综述了近十年来芳氧基稀土化合物在引发内酯、丙交酯和环碳酸酯开环聚合的研究进展,在整理聚合条件、聚合产物收率和分子量、聚合反应动力学和机理的基础上,比较了苯环上不同位置不同取代基的芳氧基配体对开环聚合反应活性的影响,得到以下结论:(1) 三(2,6-二叔丁基-4-甲基苯氧基)稀土化合物[Ln(26B4M)3]的活性最高,无取代基芳氧基稀土化合物(La(P)3)没有活性;(2)邻位叔丁基能提高活性,一个叔丁基与两个甲基效果相近;(3)甲基影响作用相对叔丁基较小,甲基越多活性越大.     

新型取代3-[(5-苄硫-1,3,4-噁二唑-2-基)甲基]苯并[d]噻(噁)唑-2(3H)-酮的合成及杀菌活性

为寻找新型高效杂环农药先导化合物,以取代苯并噻(噁)唑酮为原料,经取代、肼化、环化、苄基化反应合成了21个新型取代3-[(5-苄硫-1,3,4-噁二唑-2-基)甲基]苯并[d]噻(噁)唑-2(3H)-酮类化合物,并利用1H NMR,IR,EI-MS及元素分析对其结构进行表征.初步生物活性试验结果表明,在50 mg/L浓度下,大部分化合物对黄瓜炭疽病菌(Colletotrichum orbiculare),灰葡萄孢菌(Botrytis cinerea)和水稻纹枯病菌(Rhizoctonia solani)具有中等杀菌活性,其中化合物5b对灰葡萄胞菌和水稻纹枯病菌的抑制率均达到了85%以上.     

三氮唑并噻二唑类DOT1L抑制剂的结构修饰及活性

以DOT1L (Disruptor of telomeric silencing 1-like)抑制剂(8)为母体结构,对其核心骨架三氮唑并噻二唑两端的取代基进行结构修饰,设计合成了两个系列的三氮唑并噻二唑类结构衍生物,并测试了化合物在浓度为50μmol/L时的DOT1L酶抑制活性.结果表明,所测化合物均表现出一定的酶抑制活性,其中N,N-二甲基-4-(6-甲基-[1,2,4]三唑并[3,4-b][1,3,4]噻二唑-3-基)苯胺(14b)和(R)-{1-{{3-[4-(二甲基氨基)苯基]-[1,2,4]三唑并[3,4-b][1,3,4]噻二唑-6-基叔丁基}甲基}哌啶-3-基}氨基甲酸叔丁酯(16a)具有显著的DOT1L抑制活性,IC_(50)值分别为7.37和7.84μmol/L,与阳性对照化合物8的酶抑制活性相当.构效分析表明,当苯基连三氮唑并噻二唑部分占据S-腺苷-L-甲硫氨酸(SAM)结合位点时, R~1为4-N,N-二甲基、分子尾部R~2基团为疏水基团,适宜于分子与酶的结合,且其体积对活性影响较小.     

2-(吡啶-2-甲酰基)嘧啶类化合物的合成与生物活性研究

在2-苯甲酰基嘧啶类化合物结构优化结果基础上,定向设计合成了8个2-(吡啶-2-甲酰基)嘧啶类化合物,并对其进行了室内杀菌活性测定,结果表明这类化合物对黄瓜白粉病和黄瓜霜霉病有很好的防效.对高活性化合物6b深入筛选结果表明:6b对黄瓜白粉病有较好的预防和治疗活性,预防活性的EC50和EC90值分别为0.69和2.89 mg/L,治疗活性EC50和EC90值分别为0.13和1.6 mg/L,与对照药剂苯菌酮相当.2-氯-N-{[2-(4,6-二甲氧基嘧啶-2-甲酰基)吡啶-3-基]氧基}-N-甲基苯甲酰胺(6b)具有向上传导活性和较好的耐雨淋作用,持效期为15~20 d.     

2-取代苯亚胺基噻唑烷类化合物的晶体结构研究

A series of 2-phenyliminothiazolidines has been successfully synthesized; and 2-(2-methylphenyl) iminothiazolidine (I a) and 2-(4-methylphenyl) iminothiazolidine (I b) have been selected to determine their crystal structures by X-ray diffraction technique,from their molecular graph of it is shown that double bond at 2-carbon atom of the heterocycle is all extro-cychc at the crystal state,and there are two main plaines in I a and I b.But in I a ,the angle between the planes is 61.4° and in I b the angle is about 41.4°.And so there is a strong conjugative effect in I b than in I a.So it is thought that the difference in fungicidal activities between 2-substitutedphenyl compounds (I a) and 4-substitutedphenyl compounds(I b) is due to their space factors.     

Electrochemical synthesis of metal complexes of schiff bases: The crystal structure of bis{2-[(4-methylphenyl)iminomethyl]pyrrolato}copper(II)

The electrochemical oxidation of anodic nickel, copper, zinc or cadmium in acetonitrile solutions of Schiff bases (HL) derived from H-pyrrole-2-carbaldehyde and substituted anilines gives compounds of general formula ML₂. The crystal structure of bis{2-[(4-methylphenyl)iminomethyl]pyrrolato}copper(II) has been determined by X-ray diffraction. The compound crystallizes in the monoclinic space group P2₁/n with a = 9.356(2), b = 16.697(2), c = 14.145(2) Å and β = 108.47(2)°. The crystal structure consists of monomeric molecules in which the central CuN₄ unit has distorted square-planar geometry with a dihedral angle of 25.8(3)° between the coordination planes. The IR, ¹H NMR and UV-visible spectra of the complexes are discussed and related to the structure.     

The Synthesis And Crystal Structure Of 3-[5-Methyl-1-(4-Methylphenyl)-1,2,3-Triazol-4-yl]-s-Triazolo[3,4-b]-1,3,4-Thiadiazole

Likewise the 1,3,4-thiadiazole nucleus which incorporates an N-C-S linkage exhibits a large number of biological activities^[1]. The fused 1,3,4-triazolo[3,4-b]-1,3,4-thiadiazoles derivatives show various biological effects, such as antifungal^[2], antibacterial, hypotensive and CNS depressant activities^[3]. The novel 3-[5-methyl-1-(4-methylphenyl)-1,2,3-triazol-4-yl]-s-triazolo[3,4-b]-1,3,4-thiadiazole 6 have been synthesized by the condensation of 4-amino-5-mercapto-3-[5-methyl-1-(4-methylphenyl)-1,2,3-triazol-4-yl]-s-triazole 5 with formic acid in the presence of phosphorus oxychloride. The compound 5 was prepared from 4 that was prepared from 1 throng 2 and 3. Recently, we obtained the crystal structure of the novel compound 3-[5-methyl-1-(4-methylphenyl)-1,2,3-triazol-4-yl]-s-triazolo[3,4-b]-1,3,4-thiadiazole, C₁₄H₁₂Cl₃N₇S, Mr=416.72, Crystallizes in the triclinic space group with unit cell parameters a=9.049(2), b=10.486(3), c=10.843(2)Å, α=116.79(2), β=93.83(2), γ-100.64(3)°. V=889.3(4)ų, Z=1, Dx-0.778 Mgm^-3. The final R was 0.0535.     

双(甲基环戊二烯基)二(2,6-二氯苯氧基)铪的晶体和分子结构

本文用X-射线衍射法测定了(η⁵CH₉C₅H₄)₅H₁(OC₆H₉Cl₃-2,6)₂的晶体和分子结构.晶体结构属单科晶系,空间群为P²1/c,晶胞参数为a=17.010(2)Å,b=8.577(1)Å,C=16.313(3)Å,β=101.52(3)°,晶胞内分子数Z=4.分子内有非结晶学二次旋转轴对称性,铪原子周围的两个甲基环戊二烯基和两个氧原子构成一个变形四面体.两个环戊二烯基的平面夹角为125.33°.氧-铪-氧键角为103.71°.铪-氧键长为2.004-2.022Å,较铪-氧单键键长为短,表明具有部分双键特性.     

Synthesis and biological evaluation of some new substituted benzoxazepine and benzothiazepine as antipsychotic as well as anticonvulsant agents

Various 2-((2-((5-benzylideneamino)-1,3,4-oxa/thiadiazol-2-yl)methyl)hydrazinyl) methyl)benzo[b][1,4]oxa/thiazepin-4(5H)-ones (4a–4l), 2-((2-((5-(4-oxo-2-substitutedphenyl thiazolidin-3-yl)-1,3,4-oxa/thiadiazol-2-yl)methyl)hydrazinyl)methyl)benzo [b] [1,4]oxa/thiazepin-4(5H)-ones (5a–5l) and 2-((2-((5-(3-chloro-2-(substitutedphenyl)-4-oxoazetidin-1-yl)-1,3,4-oxa/thia diazol-2-yl)methyl)hydrazinyl)methyl)benzo[b][1,4]oxa/thiazepin-4(5H)-ones (6a–6l) have been synthesized. The structures of these compounds have been established by elemental (C, H, N) and spectral (IR, ¹H-NMR and Mass) analysis. The synthesized compounds were screened for their antipsychotic and anticonvulsant activities. Compound 5l was found to be the most active compound of this series.     

新型三唑醇衍生物的合成及抗真菌活性

依据三唑醇类化合物的构效关系, 保留基本药效团三唑环、叔醇羟基和2,4-二氟苯基, 引入新的含哌嗪侧链结构, 设计合成了12个1-(1H-1,2,4-三唑-1-基)-2-(2,4-二氟苯基)-3-取代-2-丙醇类化合物.     

3-甲基-5-氰基-6-氨基-1-苯基-4-(3,4-二甲氧基苯基)-1,4-二氢吡喃[2,3-c]吡唑的合成和晶体结构

标题化合物C22H20N4O3 3是由2-氰基-3-(3,4-二甲氧基苯基)丙烯腈1和3-甲基-1-苯基-2-吡唑-5-酮2在KF-Al2O3催化下在N,N-二甲基甲酰胺(DMF)溶剂中反应而得。结构通过单晶X-射线衍射分析确定,其晶体属于三斜晶系,空间群Pī,a = 9.450(3),b = 10.876(2), c = 11.435(2) ,a = 115.51(1), b = 102.82(1),g = 98.47(2), Mr = 388.42, V = 994.1(3) 3,Dc = 1.298 g/cm3, Z = 2, m (MoKa) = 0.089 mm-1, F(000) = 408。晶体结构用直接法解出,使用全矩阵最小二乘法对原子参数进行修正,最后的偏离因子R = 0.0420,wR = 0.1070。单晶X-射线衍射分析表明平面Ⅰ与平面Ⅱ、平面Ⅲ、平面Ⅳ的夹角分别为102.31、29.24和1.43。平面Ⅱ与平面Ⅲ和平面Ⅳ的夹角分别为73.50和100.91,平面Ⅲ和平面Ⅳ的夹角为27.81, 另外晶体中还存在分子间氢键。     

联苯甲酰-双-(缩氨基硫脲)合铜(Ⅱ)的晶体和分子结构

O用X射线衍射法测定了联苯甲酰-双-(缩氨基硫脲)合铜(Ⅱ)(以下简称CuL)的晶体及分子结构。该晶体属三斜晶系,P1空间群,α=8.9491(7),b=9.595(1),c=10.882(1)Å,α=99.42(1),β=106.19(1),γ=92.43(1)°,Z=2。R=0.025。在CuL中,Cu(Ⅱ)由螫合环的N和S原子形成变形的平面四方型配位。分子之间未形成链式结构,这与Cu-KTS不同.     

Structural characterization of two oxadiazolic systems used as spacers for potential angiotensin II receptor antagonists

The structures of two oxadiazole derivatives, methyl 2-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]benzoate (1) and methyl 2-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]benzoate2, used as spacers in the synthesis of new potential non-peptide angiotensin receptor antagonists have been determined by X-ray crystallography. In both compounds π-π interactions were observed between the oxadiazole rings and the phenyl rings of neighboring molecules. In the crystal packing of the oxadiazole 2 two C-H?O interactions are present.     

Novel 5,6-bis-(4-substitutedphenyl)-2H(3)-pyridazinones: Synthesis and reactions

A series of 5,6-bis(4-substitutedphenyl)-2H(3)-pyridazinones 2a–f have been synthesized from the condensation of the corresponding benzil monohydrazones 1 either with ethyl cyanoacetate or diethyl malonate in ethanol. The synthesized pyridazinones were converted to the corresponding 3-chloro derivatives 3a–f by the action of phosphoryl chloride. Reaction of the latter halogenated pyridazines with various aromatic amines led to the formation of new 3-aminoaryl pyridazines (4) in moderate yield. The structures of all new compounds 2b,c,e,f, 3b–e, 4 were fully identified by the analysis of their ¹H and ¹³C NMR and mass spectra. Some of these synthetic heterocyclic compounds were screened for their antimicrobial activities but they were almost negative.